Prisoline - Nasal & Eye Drops 15 ml

— rhinitis (acute, allergic), sinusitis

— nosebleeds (as a vasoconstrictor) to stop and facilitate rhinoscopy

— hay fever

— conjunctivitis (allergic, chronic)

— asthenopic disorders (violation of accommodation with increased visual stress)

— spring conjunctivitis (as part of combination therapy)

Tradename: Prisoline

Composition: Naphazoline hydrochloride (50mg / 100ml).

Chlorpheniramine maleate (50 mg / 100 ml)

Auxiliary components:

sodium citrate, boric acid, benzalkonium chloride, disodium edetate, water for injection.

Properties: Combined preparation for topical use in ophthalmology and ENT practice. It has a pronounced long-term vasoconstrictor effect, antiallergic effect, reduces the severity of local exudative manifestations, edema and hyperemia of the nasal mucosa, nasopharynx and paranasal sinuses, eliminates itching in the eyes and nose, rhinorrhea, nasal congestion, lacrimation.

Indications: As nasal drops for:

rhinitis (acute, allergic), sinusitis; nosebleeds (as a vasoconstrictor) to stop and facilitate rhinoscopy; hay fever; As eye drops for:

conjunctivitis (allergic, chronic); — astenopic disorders (violation of accommodation with increased visual stress);

— spring conjunctivitis (as part of combination therapy).

Method of administration and dosage: Eye drops:

For adults and children aged 6 years and older, the recommended dose of the drug is 1-2 drops into the conjunctival sac of the affect eye (or both eyes) up to 4 times a day.

Nasal drops: For adults and children aged 6 years and over, the recommended dose of the drug is 1-2 drops in each nasal passage 3-4 times a day.

Contraindications: The drug is contraindicated in:

— increased sensitivity to any component of the drug; — arterial hypertension; — tachycardia; — hyperthyroidism; — severe atherosclerosis; — angle-closure glaucoma; — simultaneous administration with MAO inhibitors, as well as within 14 days after their cancellation.

Precautions: It should be borne in mind that with prolonged use of Prizolin, the development of the phenomenon of tachyphylaxis (weakening of the effect) is possible. A short break is recommended after 5-7 days of drug treatment.

The use of the drug is not recommended for chronic rhinitis.

Use with caution in patients with severe cardiovascular diseases, including cardiac arrhythmias, difficult-to-control arterial hypertension, as well as in patients with diabetes mellitus, especially with a tendency to ketoacidosis.

Side effects: Side effects due to the local action of the drug: mydriasis, lacrimation, increased intraocular pressure, increased hyperemia, irritation, discomfort, burning, with prolonged use swelling of the nasal mucosa, atrophic rhinitis.

Side effects due to the systemic effect of the drug: dizziness, headache, nausea, weakness, drowsiness, irritability, increased blood pressure, tachycardia.

Storage method: At a temperature not higher than 25 degrees.

After opening, the shelf life is no longer than 4

Packaging: The cardboard box holds a 15 ml plastic bottle.